Role of Polymeric Local Drug Delivery in Multimodal Treatment of Malignant Glioma: A Review
Open Access
- 1 July 2021
- journal article
- review article
- Published by Taylor & Francis Ltd in International Journal of Nanomedicine
- Vol. ume 16, 4597-4614
- https://doi.org/10.2147/ijn.s309937
Abstract
Malignant gliomas (MGs) are the most common and devastating primary brain tumor. At present, surgical interventions, radiotherapy, and chemotherapy are only marginally effective in prolonging the life expectancy of patients with MGs. Inherent heterogeneity, aggressive invasion and infiltration, intact physical barriers, and the numerous mechanisms underlying chemotherapy and radiotherapy resistance contribute to the poor prognosis for patients with MGs. Various studies have investigated methods to overcome these obstacles in MG treatment. In this review, we address difficulties in MG treatment and focus on promising polymeric local drug delivery systems. In contrast to most local delivery systems, which are directly implanted into the residual cavity after intratumoral injection or the surgical removal of a tumor, some rapidly developing and promising nanotechnological methods-including surface-decorated nanoparticles, magnetic nanoparticles, and focused ultrasound assist transport-are administered through (systemic) intravascular injection. We also discuss further synergistic and multimodal strategies for heightening therapeutic efficacy. Finally, we outline the challenges and therapeutic potential of these polymeric drug delivery systems.Keywords
This publication has 147 references indexed in Scilit:
- Transcytosis and brain uptake of transferrin-containing nanoparticles by tuning avidity to transferrin receptorProceedings of the National Academy of Sciences of the United States of America, 2013
- Local delivery of rapamycin: a toxicity and efficacy study in an experimental malignant glioma model in ratsNeuro-Oncology, 2011
- Convection-Enhanced Delivery of Topotecan into a PDGF-Driven Model of Glioblastoma Prolongs Survival and Ablates Both Tumor-Initiating Cells and Recruited Glial ProgenitorsCancer Research, 2011
- Magnetic resonance monitoring of focused ultrasound/magnetic nanoparticle targeting delivery of therapeutic agents to the brainProceedings of the National Academy of Sciences of the United States of America, 2010
- Design and fabrication of magnetic nanoparticles for targeted drug delivery and imagingAdvanced Drug Delivery Reviews, 2010
- Progress on Antiangiogenic Therapy for Patients with Malignant GliomaJournal of Oncology, 2010
- Conductive Core–Sheath Nanofibers and Their Potential Application in Neural Tissue EngineeringAdvanced Functional Materials, 2009
- Phase II Trial of Temozolomide Plus O6-Benzylguanine in Adults With Recurrent, Temozolomide-Resistant Malignant GliomaJournal of Clinical Oncology, 2009
- Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumorsBiomaterials, 2008
- Glioma selectivity of magnetically targeted nanoparticles: A role of abnormal tumor hydrodynamicsJournal of Controlled Release, 2007